Alzheimer Disease

Taking daily anticholinergic drugs when 55 or older increases the risk of dementia, according to this nested case-control study.

A new study from ATS showed an early symptom of Alzheimer disease is more prevalent in older patients with moderate OSA.

In a recent study, investigators from Europe found using virtual reality technology can have an impact on a patient's quality of life.

Investigators found significant changes in use of Alzheimer disease drug use, use of non-Alzheimer drug use, and counseling strategies among patients subsequent to amyloid PET.

One evaluated dose of AVP-786 significantly improved scores in patients with moderate-to-severe agitation related to Alzheimer dementia, compared to placebo.

The US Department of Health and Human Services updated guidelines feature key recommendations for young children aged 3-5, youths aged 6-17, adults, older adults, pregnant and post-partum women, as well as adults with chronic health conditions and disabilities.

A 16,000-patient assessment found that infection alone, excluding critical illness, is associated with reduced brain volume later in life.

The results of a new study point to age-related macular degeneration, diabetic retinopathy, and glaucoma as potential early warning signs that an individual is at risk for developing Alzheimer disease or dementia.

If done ethically, the genetic database's collaboration with GSK could provide researchers what they really need to improve neurological care: the right patients in the right studies.

An Alzheimer’s diagnosis may cause fear, but the broad spectrum of cognitive impairment means some physicians can continue to practice despite the disease.

A survey of beliefs about Alzheimer’s disease dementia identified the stigmas that pose a hurdle to clinical trials for therapies.

Hormone therapy taken soon after menopause may help prevent memory loss.

Researchers report the monoclonal antibody solanezumab may improve cognition and activities of daily living for patients with mild Alzheimer's disease.

In the future, a simple eye test may be all that is needed to sort out individuals in the early stages of Alzheimer's disease.

The removal of Abeta from the brain is dependent on a modification related to age.

A recent study has reported that a combination of tests predicts with almost 80% certainty which patients will develop Alzheimer's.

A "prodrug" called JM6 has been found to protect against the neurodegenerative effects of both Huntington's and Alzheimer's disease in mice.

Researchers report people who are obese during middle age suffer a heightened risk of developing dementia or Alzheimer's disease.

New research shows that Alzheimer's disease and other dementing illnesses may be easily misdiagnosed in the elderly.

Speaking multiple languages may help protect cognitive health over the long term.

A team of international scientists is working on a mammoth project to create the world's first functional, virtual brain.

The FDA this week will consider a new diagnostic test that uses PET scans to identify amyloid plaques in living patients.

New research has achieved a fundamental molecular understanding of how synapses are lost in Alzheimer's disease.

A national survey reveals that roughly 76% of people surveyed would take hypothetical predictive test.

Are plaques and tangles symptoms of Alzheimer's disease, not the cause?

French neurologists and neuropsychologists have identified the elements of semantic memory.

Protein deposits linked to Alzheimer's disease can be triggered by peripheral administration outside the brain.

Research shows that family and friends are more sensitive at detecting early Alzheimer's signs than traditional tests.